Joe Burchenal and the birth of combination chemotherapy
Angela Thomas,
Angela Thomas
Department of Haematology, Royal Hospital for Sick Children, Edinburgh, UK.
Search for more papers by this authorAngela Thomas,
Angela Thomas
Department of Haematology, Royal Hospital for Sick Children, Edinburgh, UK.
Search for more papers by this authorAngela Thomas, Department of Haematology, Royal Hospital for Sick Children, Sciennes Road, Edinburgh EH9 1LF, UK.E-mail: [email protected]
Summary
When Joe Burchenal started studying medicine at the University of Pennsylvania in 1934, antibiotics had not been discovered and the survival of patients diagnosed with acute leukaemia was <4 months. By the time he retired in 1983, 58% of children with acute lymphoblastic leukaemia survived 5 years with the majority being cured of their disease. His early work in infectious diseases and antimicrobials equipped him well, both clinically and scientifically. The approach to developing antibiotics to conquer previously incurable infection was an inspiration and model for his pioneering work when searching for drugs with activity against cancer. Trials of sequential and then combination chemotherapy followed. Success in treating lymphoid malignancies in children led him to develop treatment regimens for other more resistant cancers, and as an advocate of collaborative working he introduced multimodal therapy to tackle bulky or metastatic cancers, replacing inevitable relapse with a chance of true cure.
References
- Angier, R.B., Boothe, J.H., Hutchison, B.L., Semb, J., Stokstad, E.L.R., SubbaRow, Y., Waller, C.W., Cosblich, D., Fahrenbach, M.J., Hultquist, M.E., Kun, E., Northey, E.H., Seeger, D.R., Sickels, J.P. & Smith, Jr, J.M. (1945) Synthesis of a compound identical with the L. casei isolated from liver. Science, 102, 227–228.
- Bisel, H.F. (1956) Letter to the Editor. Blood, 11, 676.
- Brubaker, C.A., Wheeler, H.E., Sonley, M.J., Williams, K.O. & Hammond, D. (1963) Cyclic chemotherapy for acute leukemia in children. Blood, 22, 820–821.
- Burchenal, J.H. (1960) Investigations in leukaemia. National Cancer Institute Monograph, 3, 149–168.
- Burchenal, J.H. (1964) Leukaemia Research Fund: 2nd Annual Guest Lecture. Approaches to the Aetiology and Treatment of Acute Leukaemia. The Queen Anne Press Ltd, London; LRF, GOS, London; Baird, Belfast.
- Burchenal, J.H. (1966) Geographic chemotherapy – Burkitt's lymphoma as a stalking horse for leukaemia. Cancer Research, 26, 2393–2405.
- Burchenal, J.H. (1977) The historical development of cancer chemotherapy. Seminars in Oncology, 4, 135–146.
- Burchenal, J.H. & Babcock, G.M. (1951) Prevention of toxicity of massive doses of A-methopterin by citrovorum factor. Proceedings of the Society for Experimental Biology and Medicine, 76, 382–384.
- Burchenal, J.H., Johnston, S.F. & Waring, G.B. (1951a) Mechanisms of amethopterin resistance in leukemia. I. Effects of weak folic acid antagonists on mouse leukemias. Proceedings of the Society for Experimental Biology and Medicine, 78, 348–351.
- Burchenal, J.H., Webber, L.F. & Johnston, S.F. (1951b) Mechanisms of amethopterin resistance in leukemia. II. Effect of cortisone on sensitive and resistant mouse leukemias. Proceedings of the Society for Experimental Biology and Medicine, 78, 352–354.
-
Burchenal, J.H.,
Karnofsky, D.A.,
Kingsley-Pillers, E.M.,
Southam, C.M.,
Myers, W.P.L.,
Escher, G.C.,
Craver, L.F.,
Dargeon, H.W. &
Roads, C.P. (1951c) The effects of the folic acid antagonists and 2,6-diaminopurine on neoplastic disease with special reference to acute leukaemia.
Cancer, 4, 549–569.
10.1002/1097-0142(195105)4:3<549::AID-CNCR2820040308>3.0.CO;2-J CAS PubMed Web of Science® Google Scholar
- Burchenal, J.H., Murphy, M.L., Ellison, R.R., Sykes, M.P., Tan, T.C., Leone, L.A., Karnofsky, M.D., Craver, L.F., Dargeon, H.W. & Rhoads, C.P. (1953) Clinical evaluation of a new antimetabolite, 6-marcaptopurine, in the treatment of leukaemia and allied diseases. Blood, 3, 965–999.
- Burchenal, J.H., Ellison, R.R., Murphy, M.L., Karnofsky, D.A., Sykes, M.P., Tan, T.C., Mermann, A.C., Yuceoglu, M., Myers, W.P., Krakoff, I. & Alberstadt, N. (1954a) Clinical studies on 6-mercaptopurine. Annals of the New York Academy of Sciences, 60, 359–368.
- Burchenal, J.H., Murphy, M.L., Yuceoglu, M. & Horsfall, M. (1954b) The effect of a new antimetabolite, O-diazoacetyl-1-serine, in mouse leukaemia. Proceedings of the American Association of Cancer Research, 1, 7.
- Christie, D.A. & Tansey, E.M. (Eds) (2003) Leukaemia. In: Wellcome Witnesses to 20th Century Medicine, Vol. 12), 86 pp. The Wellcome Trust Centre for the History of Medicine at UCL, London.
- Clarke, D.A., Philips, F.S., Sternberg, S.S., Stock, C.C., Elion, G.B. & Hitchings, G.H. (1953) 6-Mercaptopurine: effects in mouse Sarcoma 180 and in normal animals. Cancer Research, 13, 593–604.
- Clarke, D.A., Philips, F.S., Stock, C.C., Elion, G.B. & Hitchings, G.H. (1954) Combined chemotherapy of mouse sarcoma 180 (S-180), azaserine and 6-mercaptopurine. American Chemistry Society Abstracts, 125th meeting, Kansas City, KS, March.
- Dargeon, H. & Burchenal, J.H. (1951) Leukemia and neuroblastoma. Pediatrics, 8, 730–733.
- DeVita, Jr, V.T. & Serpick, A. (1967) Combination chemotherapy in the treatment of advanced Hodgkin's disease (HD). Proceedings of the American Association for Cancer Research, 8, 13.
- Djerassi, I., Royer, G., Treat, C. & Carim, H. (1968) Management of childhood lymphosarcomas and reticulum cell sarcoma with high dose methotrexate and Citrovorum factor. Proceedings of the American Association for Cancer Research, 9, 18.
- Farber, S. (1966) Chemotherapy in the treatment of leukemia and Wilms’ tumour. Journal of the American Medical Association, 198, 826–836.
- Farber, S., Cutler, E.C., Hawkins, J.W., Hartwell Harrison, J., Converse Peirce, E. & Lenz, G.G. (1947) The action of pteroyl-glutamic conjugates in man. Science, 106, 619–621.
- Farber, S., Diamond, L.K., Mercer, R.D., Sylvester, R.A. & Wolff, J.A. (1948) Temporary remissions in acute leukaemia in children produced by folic antagonist 4-aminopteroyl-glutamic acid (aminopterin). New England Journal of Medicine, 238, 787–793.
- Fernbach, D.J., Sutow, W.W., Thurman, W.G. & Vietti, T.J. (1960) Clinical trials with children in acute leukemia. Cancer Chemotherapy Reports. Part 1, 8, 102–105.
- Fildes, P. (1940) A rational approach to research in chemotherapy. Lancet, 1, 955–957.
- Freireich, E.J., Karon, M. & Frei, III, E. (1964) Quadruple combination therapy (VAMP) for acute lymphoblastic leukaemia of childhood. Proceedings of the American Association for Cancer Research, 5, 20.
- George, P. & Pinkel, D. (1965) Central nervous system radiation in children with acute lymphocytic leukaemia in remission. Proceedings of the American Association for Cancer Research, 6, 22.
- George, P., Hernandez, K., Hustu, O., Borella, L., Holton, C. & Pinkel, D. (1968) A study of ‘total therapy’ of acute lymphocytic leukaemia in children. Journal of Pediatrics, 72, 399–408.
- Goodman, L.S., Wintrobe, M.M., Dameshek, W., Goodman, M.J., Gilman, A. & McLennan, M.T. (1946) Nitrogen mustard therapy. Journal of the American Medical Association, 132, 126–132.
- Hayhoe, F.G. & Whitby, L. (1955) The management of acute leukaemia in adults. British Journal of Haematology, 1, 1–19.
- Heyn, R.M., Brubaker, C.A., Burchenal, J.H., Cramblett, H.G. & Wolff, J.A. (1960) The comparison of 6-mercaptopurine with the combination of 6-mercaptopurine and azaserine in the treatment of acute leukaemia in children: results of a cooperative study. Blood, 15, 350–359.
- Hill, J.M., Roberts, J., Loeb, E., Khan, A., MacLellan, A. & Hill, R.W. (1967) L-asparaginase therapy for leukemia and other malignant neoplasms. Remission in human leukemia. Journal of the American Medical Association, 202, 882–888.
- Johnson, I.S., Armstrong, J.G., Gorman, M. & Burnett, J.P. Jr (1963) The vinca alkaloids: a new class of oncolytic agents. Cancer Research, 23, 1390–1427.
- Klapproth, H.J. (1959) Wilms’ tumor: a report of 45 cases and an anlysis of 1351 cases reported in the world literature from 1940 to 1958. Journal of Urology, 81, 633–648.
- Krumbhaar, E.B. & Krumbhaar, H.D. (1919) The blood and bone marrow changes in yellow cross gas (mustard gas) poisoning. Changes produced in the bone marrow of fatal cases. Journal of Medical Research, 40, 497–507.
- Laszlo, J. (1995) The cure of childhood leukemia: into the age of miracles, Chapter 3. Rutgers University Press, New Brunswick, NJ.
- Leuchtenberger, C., Lewisohn, R., Laszlo, D. & Leuchtenberger, R. (1944) ‘‘Folic acid’’ a tumor growth inhibitor. Proceedings of the Society of Experimental Biology and Medicine, 55, 204–205.
- Rhoads, C.P. (1946) Nitrogen mustards in the treatment of neoplastic disease. Journal of the American Medical Association, 131, 656–658.
-
Southam, C.M.,
Craver, L.F.,
Dargeon, H.W. &
Burchenal, J.H. (1951) A study of the natural history of acute leukaemia with special reference to the duration of the disease and the occurrence of remissions.
Cancer, 4, 39–59.
10.1002/1097-0142(195101)4:1<39::AID-CNCR2820040105>3.0.CO;2-G CAS PubMed Web of Science® Google Scholar
- Tan, C.T.C., Phoa, J., Lyman, M., Murphy, M.L., Dargeon, H.W. & Burchenal, J.H. (1961) Hematological remissions in acute leukaemia with cyclophosphamide. Blood, 18, 808.
- Whiteside, J.A., Philips, F.S., Dargeon, H.W. et al. (1958) Intrathecal aminopterin in neurological manifestations of leukaemia. Archives of Internal Medicine, 101, 279–285.
-
Wilkinson, J.F. &
Fletcher, F. (1947) The effect of β-chloroethylamine hydrochlorides in leukaemia, Hodgkin's disease and polycythaemia vera – a report on 18 cases.
Lancet, ii, 540–545.
10.1016/S0140-6736(47)90586-2 Google Scholar
- Woods, D.D. (1940) The relationship of p-aminobenzoic acid to the mechanism of action of sulphanilamide. British Journal of Experimental Pathology, 21, 74–90.
- Zuelzer, W.W. (1963) Cyclic therapy and the long-term survival in childhood leukemia. Blood, 22, 840.
Citing Literature
